New York State Joins Johnson & Johnson and New York Genome Center To Initiate JLABS @ NYC

SOHO, NY — After receiving a whopping $17 million in funding from the New York State, Johnson & Johnson Innovation and the New York Genome Center will commence JLABS @ NYC, the company announced Monday. The 30,000-square-foot facility will focus on solutions within the biotechnological, pharmaceutical, and consumer health sectors. The collaboration arrives after the Cuomo administration's $650 million initiative to improve biotechnology in New York.

In addition to offering laboratory facilities to biotech-oriented startups, JLABS aims to connect local entrepreneurs to Johnson & Johnson Innovation where they can benefit from the institution's robust monetary assistance and in-depth insight from medical experts and various informational events, Johnson & Johnson said in a press release.

In spite of hosting over 100 research foundations and nine medical centers, New York City continues to face a dearth in solid infrastructure to support entrepreneurs in life sciences. JLABS @ NYC aims to bridge that gap between institutional support and local innovation with the help of its facilities and technology.

"New York is poised to be a global leader in this industry, and the new, vital incubator JLABS will be the catalyst that pushes our state into the forefront of this exciting field," said Gov. Andrew Cuomo.

Image via Shutterstock